IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX
HealthcareNASDAQUnited States
571.64USD-6.87 (-1.19%)

About IDEXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the companion animal veterinary, livestock and poultry, dairy and water testing markets globally.

The company is organized into four segments:

  • CAG (Companion Animal Group): Provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits. It also offers veterinary reference laboratory diagnostic and consulting services, as well as practice management and diagnostic imaging systems and services for veterinarians.

  • Water Quality Products: Supplies products that test for various microbiological contaminants in water, enhancing public and environmental health.

  • LPD (Livestock, Poultry, and Dairy): Delivers diagnostic and health-monitoring products for managing animal health in livestock, poultry, and dairy sectors.

  • Other: Includes offerings such as health monitoring and biological materials testing for the biomedical research community, point-of-care electrolytes and blood gas analyzers, and SARS-CoV-2 RT-PCR used in human medical diagnostics.

Additionally, IDEXX provides veterinary software and services for independent veterinary clinics and corporate groups, and markets products such as the Colilert, Colilert-18, and Colisure tests for detecting total coliforms and E. coli in water.

The company’s comprehensive product portfolio is marketed through direct sales, customer service, and technical service groups, as well as through independent distributors and resellers.

Founded in 1983, IDEXX Laboratories is headquartered in Westbrook, Maine.

IDEXX's Business Strategy

​IDEXX Laboratories operates a specialized business model focused on delivering diagnostic and software solutions for animal health, water quality, and livestock and poultry diagnostics. The company's strategy centers on innovation, customer-centricity, and expanding its global footprint to maintain leadership in its core markets.​

At the heart…

Available on Finplify

Free account required

Sign up free

Our Take on IDEXX

Pros:

Veterinary Diagnostics Leader: IDEXX holds a leading position in companion animal diagnostics, offering a broad range of in-clinic tools, lab services, and digital solutions.

Recurring Revenues: A significant portion of IDEXX’s revenue comes from recurring, high-margin consumables and diagnostic services tied to its…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
NASDAQ
Country
United States
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky
Employees
11,000
IPO Date
1991-06-21
ISIN
US45168D1046
Website
idexx.com

Key Metrics

Market Cap
45.65BUSD
P/E Ratio (TTM)
43.74
Net Profit Margin
24.62%
Debt / Asset Ratio
0.32
Dividend Yield (TTM)
0.00%
Volume
45,104
Avg Volume
545,491
Shares Outstanding
79.85M
Free Float
98.90%
β Beta
1.66
52W Range
356.1 - 770.0

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
5.0/5Excellent
Liquidity
2.6/5Average
Leverage
4.0/5Good
Cash Flow
4.5/5Excellent
Valuation
2.8/5Average

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on IDEXX

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.